GlassScriptPhysician profile
Mark Carlton Brown
NPI 1225021264
$5,410.95
in general payments reported to CMS, 2019-2025
37 companies · $17.23 in 2025
The $17.23 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,173 · 2020: $965 · 2021: $1,851 · 2022: $1,307 · 2023: $96.67 · 2025: $17.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $611.32 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $572.93 | 2019-2022 | |
| Abbvie INC. | $413.35 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $369.91 | 2019-2022 | |
| Pfizer INC. | $362.56 | 2019-2022 | |
| Abbott Laboratories | $347.42 | 2019-2025 | Freestyle Libre 2, Assurity, Proclaim |
| Astellas Pharma US INC | $313.53 | 2019-2022 | |
| Amarin Pharma, INC. | $295.86 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $208.45 | 2019-2022 | |
| Daiichi Sankyo INC. | $185.27 | 2020-2021 | |
| Glaxosmithkline, LLC. | $178.80 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $172.47 | 2019-2022 | |
| Novo Nordisk INC | $154.37 | 2019-2022 | |
| Vanda Pharmaceuticals INC. | $114.49 | 2019-2022 | |
| Radius Health, INC. | $113.97 | 2019-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $99.43 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $95.55 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $90.82 | 2021-2022 | |
| Boston Scientific Corporation | $87.10 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.21 | 2019-2022 | |
| Philips North America LLC | $54.69 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.87 | 2021-2022 | |
| Lucid Diagnostics INC. | $50.97 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $50.81 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.85 | 2021 | |
| Esperion Therapeutics, INC. | $44.47 | 2020-2022 | |
| Nalu Medical, INC. | $40.22 | 2021-2022 | |
| Edwards Lifesciences Corporation | $35.15 | 2020-2021 | |
| Alphatec Spine, INC | $31.54 | 2021 | |
| Lilly USA, LLC | $28.46 | 2019-2022 | |
| Ethicon US, LLC | $23.47 | 2022 | |
| Depuy Synthes Sales INC. | $23.36 | 2019 | |
| Alfasigma USA, INC. | $22.63 | 2020 | |
| Sanofi Pasteur INC. | $15.62 | 2021 | |
| Strongbridge US INC. | $15.50 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.98 | 2022 | |
| Apria Healthcare LLC | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.